Abstract
Background Patients’ knowledge of their medications play a pivotal role in their disease management. Objective Assess the knowledge and practices of Lebanese outpatients regarding their own medication use and risks. Setting Four hundred and sixty community pharmacies across Lebanon. Method It was a cross-sectional study performed from March through May 2016 among Lebanese outpatients, using a self-administered questionnaire. Descriptive statistics were used to calculate all participants’ responses. The association between categorical variables were evaluated using Pearson χ2 test or Fisher’s exact test. Binary logistic regressions were performed to identify factors associated with medication patients’ knowledge and interest. Main outcome measure Ability of the patients to identify own medications’ elements: name, strength, dosage regimen, indication, and adverse drug reactions. Results Our study comprised 921 patients, with around 16% taking ≥5 medications/day. Around 56% of our patients showed sub-optimal medication knowledge. Patients’ higher educational level, number of chronic diseases, and patient physician interaction were associated with higher medication knowledge. Many patients admitted not discussing their medications each time they visit their physicians (38.7%); not reading the leaflet of each medication they take (61.2%); and not regularly asking their pharmacist about the potential interactions of OTC drugs with prescribed medications (53.9%). Conclusion This study showed suboptimal medication-related knowledge, and suboptimal patient’s interactions with primary care givers. Our findings serve as a platform for healthcare providers to understand patients’ needs and educate them about medication use and risks.
Similar content being viewed by others
References
Cox A. Involving patients in reporting adverse drug reactions should be welcomed. Pharm J. 2009;282:16.
Josef Send AF, Schwab M, Gauss A, Rudofsky G, HaefelI WE, Seidling HM. Pilot study to assess the influence of an enhanced medication plan on patient knowledge at hospital discharge. Eur J Clin Pharmacol. 2014;70:1243–50.
Hong SH, Liu J, Tak S, Vaidya V. The impact of patient knowledge of patient-centered medication label content on quality of life among older adults. Res Social Adm Pharm. 2013;9:37–48.
Burge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T et al. Correlates of medication knowledge and adherence: findings from the residency research network of South Texas. Fam Med. 2005;37(10):712–8.
Najjar A, Amro Y, Kitaneh I, Abu-ShararS Sawalha M, Jamous A, et al. Knowledge and adherence to medications among palestinian geriatrics living with chronic diseases in the West Bank and East Jerusalem. PLoS One. 2015;10(6):e0129240.
Okuyan B, Sancar M, Izzetin FV. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings. Pharmacoepidemiol Drug Saf. 2013;22:209–14.
McPherson ML, Smith SW, Powers A, Zuckerman IH. Association between diabetes patients’ knowledge about medications and their blood glucose control. Res Social Adm Pharm. 2008;4(1):37–45.
Necyk C, Barnes J, Tsuyuki RT, Boon H, Vohra S. How well do pharmacists know their patients? A case report highlighting natural health product disclosure. Can Pharm J. 2013;146(4):202–9.
Cumbler E, Wald H, Kutner J. Lack of patient knowledge regarding hospital medications. J Hosp Med. 2010;5:83–6.
Leemans L, Heylen N, Quanten A, Deferme S. Consumer study on the use of patient information leaflets. [Article in French]. J Pharm Belg. 2011;4:109–16.
Sleath B, Roter D, Chewning B, Svarstad B. Asking questions about medication: analysis of physician-patient interactions and physician perceptions. Med Care. 1999;37(11):1169–73.
Garjani A, Rahbar M, Ghafourian T, Maleki N, Garjani A, Salimnejad M et al. Relationship of pharmacist interaction with patient knowledge of dispensed drugs and patient satisfaction. East Mediterr Health J. 2009;15(4):934–43.
European Medicines Agency (EMA). Product-information templates. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000134.jsp (2016). Accessed 05 Aug 2016.
U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); and Center for Biologics Evaluation and Research (CBER). Guidance: Useful Written Consumer Medication Information (CMI). http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080602.pdf (2006). Accessed 06 Aug 2016.
National Patient Safety Foundation (NPSF). Ask Me 3: Good Questions for Your Good Health 2016. http://www.npsf.org/?page=askme3. Accessed 07 Aug 2016.
Rubio JS, García-Delgado P, Iglésias-Ferreira P, Mateus-Santos H, Martínez-Martínez F. Measurement of patients’ knowledge of their medication in community pharmacies in Portugal. Cien Saude Colet. 2015;20(1):219–28.
Romero-Sanchez J, Garcia-Cardenas V, Abaurre R, Martínez-Martínez F, Garcia-Delgado P. Prevalence and predictors of inadequate patient medication knowledge. J Eval Clin Pract. 2016;22(5):808–15.
Akici A, Kalaca S, Ugurlu U, Toklu HZ, Iskender E, Oktay S. Patient knowledge about drugs prescribed at primary healthcare facilities. Pharmacoepidemiol Drug Saf. 2004;13:871–6.
Ghusn H. Polypharmacy: what clinicians need to know while caring for an elderly. J Med Liban. 2012;60(4):207–13.
Yassine M, Al-Hajje A, Awada S, Rachidi S, Zein S, Bawab W et al. Evaluation of medication adherence in Lebanese hypertensive patients. J Epidemiol Glob Health. 2016;6(3):157–67.
Al-Hajje A, Awada S, Rachidi S, Zein S, Bawab W, El-Hajj Z, et al. Factors affecting medication adherence in Lebanese patients with chronic diseases. Pharm Pract. 2015;13(3):590.
Saab YB, Hachem A, Sinno S, El-Moalem H. Inappropriate medication use in elderly lebanese outpatients: prevalence and risk factors. Drugs Aging. 2006;23(9):743–52.
Saarti S, Hajj A, Karam L, Jabbour H, Sarkis A, El Osta N et al. Association between adherence, treatment satisfaction and illness perception in hypertensive patients. J Hum Hypertens. 2016;30:341–5.
Zeenny R, Wakim S, Kuyumjian YM. Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clin Interv Aging. 2017;12:65–73. doi:10.2147/CIA.S87564.
Al-Hajje A, Awada S, Rachidi S, Chahine NB, Azar R, Zein S et al. Medication prescribing errors: data from seven Lebanese hospitals. J Med Liban. 2012;60(1):37–44.
Ramia E, Zeenny R. Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study. Patient Prefer Adherence. 2014;8:1195–204.
World Health Organization Regional Office for Europe. Exploring patient participation in reducing health-care-related safety risks. DK-2100 Copenhagen, Denmark; 2013.
World Fact Book of the United States Central Intelligence Agency. 2016. Lebanon Demographics Profile 2014. http://www.indexmundi.com/lebanon/demographics_profile.html. Accessed 19 Nov 2015.
Dean AG, Arner TG, Sunki GG, Friedman R, Lantinga M, Sangam S et al. Epi Info™, a database and statistics program for public health professionals. Atlanta: CDC; 2011.
Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007;26(3):731–40.
Oladimeji O, Farris KB, Urmie JG, Doucette WR. Risk factors for self-reported adverse drug events among medicare enrollees. Ann Pharmacother. 2008;42(1):53–61.
Raynor K, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2004;264(7083):268–70.
Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets on patient behavior. IMAJ. 2007;9:383–6.
Nathan JP, Zerilli T, Cicero LA, Rosenberg JM. Patients’ use and perception of medication information leaflets. Ann Pharmacother. 2007;41(5):777–82.
Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S. Patient information leaflets: informing or frightening? BMC Fam Pract. 2014;2014(15):163.
Krueger JL, Hermansen-Kobulnicky CJ. Patient perspective of medication information desired and barriers to asking pharmacists questions. J Am Pharm Assoc. 2011;51(4):510–9.
Zeenny R., Forecasting the Future of Pharmacy In Lebanon: The Magic Of Numbers, in The Lebanese Order of Pharmacists Pharmacy Day 2016 conference presentation; 2016.
Obamiro KO, Chalmers L, Bereznicki LRE. Development and validation of an oral anticoagulation knowledge tool (AKT). PLoS One. 2016;11(6):e0158071. doi:10.1371/journal.pone.0158071.
Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633–8.
Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40–59.
Acknowledgements
We would like to thank all the inspectors of the OPL for their help in passing the surveys and data entry. We would also like to thank all the members of the OPL Medication Safety Subcommittee, namely: Aline Hajj, Hadi Sherri, Hayat Azouri, Hind Hajj, Maryam Ghorayeb, Marwan Akel, Nouhad Sarkis, and Patricia Shuhaiber.
Funding
No sources of funding were used to assist in the preparation of this study.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflicts of interest
The authors of this manuscript declare no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ramia, E., Zeenny, R.M., Hallit, S. et al. Assessment of patients’ knowledge and practices regarding their medication use and risks in Lebanon. Int J Clin Pharm 39, 1084–1094 (2017). https://doi.org/10.1007/s11096-017-0517-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-017-0517-4